Breaking News, Financial News

Financial Report: Catalent 3Q

Oral Technologies drive growth in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Catalent   3Q Revenues: $446.6 million (+8%) 3Q Earnings: $31.5 million (earnings were $6.7 million 3Q14) YTD Revenues: $1.3 billion (+1%) YTD Earnings: $58.5 million (loss of $11.0 million YTD14) Comments: Growth was driven by the Oral Technologies segment ($284.0 million, +10% at constant currency) and increased demand for analytical services integrated operations within its Development and Clinical Services segment with $103.7 million for the quarter, up 4% at constant currency. Revenue ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters